Wits launches SA’s second Covid-19 vaccine trial

United States News News

Wits launches SA’s second Covid-19 vaccine trial
United States Latest News,United States Headlines
  • 📰 BDliveSA
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 63%

The phase 2b trial will evaluate the safety of experimental shot and its ability to stimulate the body’s immune system to protect against future infection

Wits University has launched its second Covid-19 vaccine trial, testing an experimental shot made by US biotech company Novavax, supported in part by a $15m grant from the Bill & Melinda Gates Foundation.

The phase 2b trial of the shot called NVX-CoV2373 will enrol about 2,900 adult volunteers, including 240 who are HIV positive. It will evaluate the shot’s safety and ability to stimulate the body’s immune system to protect against future infection with Sars-CoV-2, the virus that causes Covid-19.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

BDliveSA /  🏆 12. in ZA

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Wits launches SA’s second Covid-19 vaccine trialThe phase 2b trial will evaluate the safety of experimental shot and its ability to stimulate the body’s immune system to protect against future infection
Read more »

Hunt laments Wits for not taking chances against Orlando PiratesWits coach Gavin Hunt believes his team should have got all three points against Orlando Pirates but instead the game ended in a goalless draw IOLsport PSL
Read more »

Wits launches SA’s second Covid-19 vaccine trialThe phase 2b trial will evaluate the safety of experimental shot and its ability to stimulate the body’s immune system to protect against future infection
Read more »

COVID-19: Novavax begins mid-stage study of Covid-19 vaccine in South AfricaCOVID-19: Novavax begins mid-stage study of Covid-19 vaccine in South AfricaAug 17 (Reuters) - U.S. drug developer Novavax Inc said on Monday that it is starting a mid-stage study of its experimental COVID-19 vaccine in South Africa, as the country experiences a surge in coronavirus cases.
Read more »

Britain encourages at-risk groups to sign up for COVID-19 vaccine trialsBritain encourages at-risk groups to sign up for COVID-19 vaccine trialsNo COVID-19 vaccine candidate has yet been proven effective against the disease, but around 20 are in clinical trials.
Read more »

COVID-19 LIVE UPDATES | Alarm over state instruction to test bodies for Covid-19All the Covid-19 news from SA and around the world
Read more »



Render Time: 2025-03-01 11:03:07